Biogen BIIB
NASDAQ BIIB
$216.78 +2.43 (+1.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biogen (BIIB) Other Non Operating Income (2009 - 2015)

Biogen (BIIB) posted quarterly Other Non Operating Income of -$15.0 million for Q1 2015, down 167.56% year-over-year from $22.2 million in Q1 2014, and down 70.88% quarter-over-quarter from -$8.8 million in Q4 2014.

Biogen (BIIB) Other Non Operating Income (2009 - 2015) Analysis & Trends

Biogen's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$15.0 million for Q1 2015.

  • In Q1 2015, Other Non Operating Income fell 167.56% year-over-year to -$15.0 million; the TTM figure through Mar 2015 stood at -$35.2 million (down 35.1% YoY), while the FY2016 annual figure was -$217.4 million, down 75.75% from the prior year.
  • Other Non Operating Income for Q1 2015 stood at -$15.0 million, down from -$8.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $15.1 million in Q1 2012, with the low at -$17.4 million in Q1 2011.
  • The 5-year median for Other Non Operating Income is -$5.6 million (2014), against an average of -$6.2 million.
  • The sharpest annual moves came in 2012 and 2013: Other Non Operating Income surged 73850.0% in 2012, then tumbled 453.49% in 2013.
  • Biogen's Other Non Operating Income stood at -$4.0 million in 2011, then plunged by 259.68% to -$14.3 million in 2012, then soared by 62.39% to -$5.4 million in 2013, then plunged by 63.16% to -$8.8 million in 2014, then slumped by 70.88% to -$15.0 million in 2015.
  • Business Quant data shows BIIB's Other Non Operating Income at -$15.0 million in Q1 2015, -$8.8 million in Q4 2014, and -$16.3 million in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Biogen 32.04 Bn 30.76 Bn 1.96 Bn

Historic Data

Download Data
DateValue
Mar 31, 2015 -14.99 Mn
Dec 31, 2014 -8.77 Mn
Sep 30, 2014 -16.29 Mn
Jun 30, 2014 4.86 Mn
Mar 31, 2014 -5.60 Mn
Dec 31, 2013 -5.38 Mn
Sep 30, 2013 -4.64 Mn
Jun 30, 2013 -10.43 Mn
Mar 31, 2013 -14.46 Mn
Dec 31, 2012 -14.29 Mn
Sep 30, 2012 -4.55 Mn
Jun 30, 2012 2.95 Mn
Mar 31, 2012 15.14 Mn
Dec 31, 2011 -3.97 Mn
Sep 30, 2011 -7.73 Mn
Jun 30, 2011 -4,000.00
Mar 31, 2011 -17.38 Mn
Dec 31, 2010 -4.70 Mn
Sep 30, 2010 -6.90 Mn
Jun 30, 2010 1.00 Mn